Mutant Tau (P301L) Enhances Global Protein Translation in Differentiated SH-SY5Y Cells by Upregulating mTOR

Giovanni Luca Cipriano1, Alessia Floramo1, Veronica Argento1

  • 1IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.

Insights

Mutant Tau protein significantly boosts global protein synthesis in human neurons by activating the mTOR/S6 pathway. This Tau-driven increase in translation is dependent on mTOR signaling and may contribute to tauopathy progression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Altered protein synthesis is implicated in aging and neurodegenerative diseases like Alzheimer's.
  • Hyperphosphorylated Tau accumulation in tauopathies disrupts cellular processes, including mRNA translation.
  • The precise impact of Tau on global protein synthesis in human neurons is not fully understood.

Purpose of the Study:

  • To investigate the effects of mutant Tau protein expression on global protein synthesis in human neurons.
  • To elucidate the molecular pathways involved in Tau-mediated translational regulation.

Main Methods:

  • Utilized SH-SY5Y cells overexpressing the P301L mutant Tau protein.
  • Quantified global protein synthesis using the Surface Sensing of Translation (SUnSET) puromycin-incorporation assay.
  • Assessed the role of the mTOR/S6 pathway and the effect of rapamycin treatment.

Main Results:

  • Expression of Tau-P301L significantly increased global protein synthesis.
  • This upregulation was mediated by the activation of the mTOR/S6 signaling pathway.
  • Rapamycin treatment abolished the Tau-induced increase in translation, confirming mTOR dependency.

Conclusions:

  • Mutant Tau protein enhances global protein synthesis in human neurons via mTOR/S6 pathway activation.
  • Tau-induced translational alterations may contribute to the progression of tauopathies.
  • The mTOR signaling pathway represents a potential therapeutic target for tauopathies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K